Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03967223
Title Master Protocol to Assess the Safety and Antitumor Activity of Genetically Engineered T Cells in NY-ESO-1 and/or LAGE-1a Positive Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors GlaxoSmithKline
Indications

synovial sarcoma

Therapies

Cyclophosphamide + Fludarabine + NY-ESO-1-c259T

Age Groups: senior | child | adult
Covered Countries USA | ITA | FRA | ESP | CAN

Facility Status City State Zip Country Details
GSK Investigational Site Recruiting Duarte California 91010 United States Details
GSK Investigational Site Recruiting Stanford California 94305 United States Details
GSK Investigational Site Recruiting Denver Colorado 80218 United States Details
GSK Investigational Site Recruiting Jacksonville Florida 32224 United States Details
GSK Investigational Site Recruiting Chicago Illinois 60637 United States Details
GSK Investigational Site Recruiting Iowa City Iowa 52242-1009 United States Details
GSK Investigational Site Recruiting Boston Massachusetts 02114 United States Details
GSK Investigational Site Recruiting Boston Massachusetts 02114 United States Details
GSK Investigational Site Recruiting Ann Arbor Michigan 48109 United States Details
GSK Investigational Site Recruiting Minneapolis Minnesota 55455 United States Details
GSK Investigational Site Recruiting Rochester Minnesota 55905 United States Details
GSK Investigational Site Recruiting Saint Louis Missouri 63110 United States Details
GSK Investigational Site Recruiting New York New York 10065 United States Details
GSK Investigational Site Recruiting Durham North Carolina 27710 United States Details
GSK Investigational Site Recruiting Columbus Ohio 43210 United States Details
GSK Investigational Site Recruiting Portland Oregon 97239 United States Details
GSK Investigational Site Recruiting Pittsburgh Pennsylvania 15232 United States Details
GSK Investigational Site Recruiting Nashville Tennessee 37203 United States Details
GSK Investigational Site Recruiting Dallas Texas 75390-8565 United States Details
GSK Investigational Site Recruiting Dallas Texas 75390-9063 United States Details
GSK Investigational Site Recruiting Salt Lake City Utah 84112 United States Details
GSK Investigational Site Recruiting Richmond Virginia 23298 United States Details
GSK Investigational Site Recruiting Seattle Washington 98109-1024 United States Details
GSK Investigational Site Recruiting Milwaukee Wisconsin 53226 United States Details
GSK Investigational Site Recruiting Toronto Ontario M5G 2M9 Canada Details
GSK Investigational Site Recruiting Montreal Quebec H1T 2M4 Canada Details
GSK Investigational Site Recruiting Lyon cedex 08 69373 France Details
GSK Investigational Site Recruiting Pessac cedex 33604 France Details
GSK Investigational Site Recruiting Milano Lombardia 20133 Italy Details
GSK Investigational Site Recruiting Rozzano (MI) Lombardia 20089 Italy Details
GSK Investigational Site Recruiting Amsterdam 1066 CX Netherlands Details
GSK Investigational Site Recruiting Barcelona 08025 Spain Details
GSK Investigational Site Recruiting Hospitalet de Llobregat, Barcelona 08907 Spain Details
GSK Investigational Site Recruiting Madrid 28040 Spain Details
GSK Investigational Site Recruiting Sevilla 41013 Spain Details
GSK Investigational Site Recruiting London SW3 6JJ United Kingdom Details
GSK Investigational Site Recruiting London WC1E 6AG United Kingdom Details
GSK Investigational Site Recruiting Manchester M20 4BX United Kingdom Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field